ÍøºìºÚÁÏ

Skip to main content

R. David Anderson, MD, MS, FACC, FSCAI

Cardiologist (Heart Specialist), Interventional Cardiologist, Internist

Photo of R. David Anderson

Research at a glance

Top areas of exploration

  • Myocardial Infarction , 22 publications
  • Myocardial Ischemia , 15 publications
  • Coronary Artery Disease , 14 publications
  • Coronary Circulation , 10 publications

Research activity

111 publications

7,441 citations

Why is this important?

Active clinical trials

CardiALLO-HF
Investigator
R. David Anderson
Status
Accepting Candidates
PROTECT IV

The purpose of this study is to assess if using the Impella® CP (or Impella® 2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart function and health after a heart…

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
18 Years - 90 Years
Sexes
All
CardiAMP

This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham control treatment. A roll-in phase with a maximum of 10 subjects may occur.

Investigator
R. David Anderson
Status
Accepting Candidates
Ages
21 Years - 90 Years
Sexes
All

My publications

111 publications

2021

Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

New England Journal of Medicine

2020

Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study.

Journal of the American Heart Association

•

2020

Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 Era

The American Journal of Medicine

•

2020

Design, methodology and baseline characteristics of the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD).

American heart journal

•

2020

Does ischemia also change as we age?

Jacc-Cardiovascular Interventions